Agency
Niagara Falls Memorial Medical Center
Niagara Falls Memorial Medical Center was paid $59.86M by Medicaid between Jan 2018 and Dec 2024, across 334 billing codes. Its largest line is G9005, Coordinated care fee, risk adjusted maintenance — 34% of everything it billed.
33Billing provider infoNIAGARA FALLS MEMORIAL MEDICAL CENTER
NIAGARA FALLS, NY 14302
NIAGARA FALLS, NY 14302
33aNPI1285717298assigned 10/23/2006
33bProvider typeCase Management Agency
28Total paid$59.86M
24GClaims966,427
24DCodes billed334
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Case Management Agency providers in New York
Rank by total paid#26 of 180
Median peer was paid$1.76M
This provider vs. median34×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,522 | $281K | |
| 2019 | 91,087 | $6.71M | |
| 2020 | 203,600 | $16.44M | |
| 2021 | 196,977 | $13.79M | |
| 2022 | 166,288 | $8.40M | |
| 2023 | 168,551 | $8.18M | |
| 2024incomplete | 129,402 | $6.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G9005 | Coordinated care fee, risk adjusted maintenance | 34% | 78,220 | 78,162 | $20.27M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 106,619 | 90,040 | $7.38M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 6.2% | 33,428 | 24,174 | $3.71M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.6% | 15,079 | 14,308 | $2.13M |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.1% | 13,008 | 7,680 | $1.88M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.8% | 13,486 | 12,697 | $1.66M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.5% | 17,361 | 14,092 | $1.49M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.4% | 19,445 | 18,418 | $1.45M |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 3,918 | 3,806 | $1.14M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 8,216 | 7,656 | $1.04M |
| G9001 | Coordinated care fee, initial rate | 1.7% | 13,707 | 13,706 | $1.02M |
| G0378 | Hospital observation service, per hour | 1.4% | 809 | 373 | $850K |
322 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 6,358 | $848K |
| 80053 | Comprehensive metabolic panel | 1.2% | 38,146 | $741K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 5,319 | $707K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.1% | 7,876 | $664K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 8,248 | $593K |
| 97602 | <1% | 1,315 | $561K | |
| T2022 | Case management, per month | <1% | 1,831 | $506K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,933 | $500K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 3,162 | $493K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 8,142 | $491K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 5,225 | $488K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,760 | $480K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,063 | $361K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 7,535 | $361K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 677 | $358K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 4,394 | $317K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 2,601 | $300K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 7,641 | $296K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,052 | $280K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,934 | $271K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 8,571 | $256K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 3,993 | $249K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,661 | $243K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 7,324 | $222K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 9,727 | $202K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 618 | $179K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 489 | $174K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,490 | $167K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 221 | $158K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,349 | $139K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 6,498 | $132K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,626 | $129K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,316 | $126K |
| 80061 | Lipid panel | <1% | 14,632 | $122K |
| 97161 | <1% | 1,431 | $119K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,074 | $118K |
| 1159F | <1% | 5,149 | $113K | |
| 83880 | <1% | 4,083 | $110K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 5,667 | $109K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,151 | $108K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,629 | $100K |
| 93975 | <1% | 489 | $97K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,561 | $93K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 677 | $92K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 756 | $86K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,025 | $79K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12,539 | $77K |
| 90715 | <1% | 2,227 | $75K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,026 | $69K |
| 12001 | <1% | 177 | $67K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,640 | $66K |
| 84439 | <1% | 10,851 | $65K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 956 | $61K |
| 82607 | <1% | 7,317 | $61K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,266 | $60K |
| 93976 | <1% | 699 | $56K | |
| 86850 | <1% | 2,249 | $54K | |
| 90686 | <1% | 2,121 | $53K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,818 | $53K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 451 | $52K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,538 | $52K |
| 93015 | <1% | 876 | $51K | |
| 93970 | <1% | 210 | $46K | |
| 82746 | <1% | 5,761 | $45K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 33,310 | $44K |
| 85008 | <1% | 3,736 | $43K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,358 | $42K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,140 | $40K |
| 71271 | <1% | 556 | $40K | |
| 93000 | <1% | 3,059 | $38K | |
| 86901 | <1% | 2,485 | $36K | |
| 99385 | <1% | 321 | $34K | |
| 86900 | <1% | 2,489 | $32K | |
| 1160F | <1% | 694 | $31K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,105 | $29K |
| 10060 | <1% | 97 | $29K | |
| 93971 | <1% | 411 | $28K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,437 | $28K |
| 81001 | <1% | 19,723 | $27K | |
| 76818 | <1% | 441 | $27K | |
| 82728 | <1% | 2,503 | $27K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,102 | $26K |
| 3074F | <1% | 1,088 | $26K | |
| 99406 | <1% | 1,076 | $25K | |
| 86803 | <1% | 4,892 | $23K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 702 | $23K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 655 | $22K |
| 82570 | <1% | 6,820 | $21K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,298 | $20K |
| 82043 | <1% | 6,528 | $20K | |
| 59025 | Fetal non-stress test | <1% | 1,263 | $20K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 923 | $18K |
| 76801 | <1% | 236 | $18K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 319 | $17K |
| 87070 | <1% | 5,581 | $17K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,344 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,315 | $17K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $16K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 24 | $16K |
| 99386 | <1% | 133 | $16K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 108 | $15K |
| 76813 | <1% | 226 | $15K | |
| 83735 | <1% | 10,556 | $13K | |
| 90732 | <1% | 252 | $12K | |
| 86780 | <1% | 1,554 | $11K | |
| 72110 | <1% | 1,086 | $11K | |
| 85610 | <1% | 7,794 | $10K | |
| 84153 | <1% | 736 | $10K | |
| 86141 | <1% | 1,219 | $10K | |
| 70486 | <1% | 448 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 701 | $9K |
| 87522 | Neg quan hep c or qual rna | <1% | 222 | $9K |
| 87340 | <1% | 1,350 | $9K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 132 | $9K |
| 83540 | <1% | 2,295 | $9K | |
| 73562 | <1% | 1,606 | $8K | |
| 83550 | <1% | 2,185 | $8K | |
| 83655 | <1% | 611 | $8K | |
| 86762 | <1% | 888 | $8K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 109 | $8K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,248 | $7K |
| 99051 | <1% | 626 | $7K | |
| 73030 | <1% | 1,506 | $7K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 481 | $7K |
| 92228 | <1% | 81 | $7K | |
| 3079F | <1% | 190 | $7K | |
| 3075F | <1% | 153 | $6K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 93 | $6K |
| 87088 | <1% | 2,345 | $5K | |
| D0120 | Dental checkup, returning patient | <1% | 134 | $5K |
| 84550 | <1% | 1,850 | $5K | |
| 0001A | <1% | 173 | $5K | |
| 85730 | <1% | 5,521 | $5K | |
| 73630 | <1% | 1,495 | $5K | |
| 0004A | <1% | 122 | $5K | |
| 59430 | <1% | 39 | $5K | |
| 82948 | <1% | 3,942 | $5K | |
| 97597 | <1% | 20 | $4K | |
| 84702 | <1% | 1,367 | $4K | |
| 1000F | <1% | 689 | $4K | |
| 73130 | <1% | 1,320 | $4K | |
| 87077 | <1% | 2,130 | $4K | |
| 90836 | <1% | 55 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $4K |
| 99223 | Prolong inpt eval add15 m | <1% | 58 | $4K |
| 72141 | <1% | 13 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,873 | $4K |
| 90661 | <1% | 115 | $4K | |
| 0071A | <1% | 97 | $4K | |
| 0002A | <1% | 145 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,721 | $4K |
| 99080 | <1% | 2,064 | $4K | |
| 0012A | <1% | 189 | $4K | |
| 0072A | <1% | 91 | $4K | |
| 73610 | <1% | 1,164 | $3K | |
| 92250 | <1% | 56 | $3K | |
| 99221 | <1% | 146 | $3K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 40 | $3K |
| 85027 | <1% | 1,674 | $3K | |
| 76536 | <1% | 132 | $3K | |
| 87186 | <1% | 1,951 | $3K | |
| 86787 | <1% | 587 | $3K | |
| G0008 | Administration of influenza virus vaccine | <1% | 241 | $3K |
| 0011A | <1% | 201 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,972 | $3K |
| D1110 | Prophylaxis - adult | <1% | 55 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 37 | $2K |
| 85651 | <1% | 1,524 | $2K | |
| 84703 | <1% | 8,246 | $2K | |
| 82550 | <1% | 4,872 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,020 | $2K |
| 86769 | <1% | 139 | $2K | |
| 72100 | <1% | 689 | $2K | |
| 86706 | <1% | 315 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 27 | $2K |
| 90670 | <1% | 37 | $2K | |
| 73502 | <1% | 525 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 435 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,632 | $2K |
| 76641 | <1% | 118 | $2K | |
| 88313 | <1% | 695 | $2K | |
| 90750 | <1% | 13 | $2K | |
| 73110 | <1% | 452 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 328 | $2K |
| 82652 | <1% | 156 | $2K | |
| 84484 | <1% | 6,326 | $2K | |
| 73564 | <1% | 253 | $2K | |
| 83020 | <1% | 182 | $2K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 13 | $2K |
| 86580 | <1% | 93 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 332 | $2K |
| 81003 | <1% | 1,377 | $2K | |
| 72040 | <1% | 403 | $2K | |
| 0064A | <1% | 38 | $2K | |
| 83690 | <1% | 4,942 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 332 | $1K |
| 94760 | <1% | 364 | $1K | |
| 86480 | <1% | 26 | $1K | |
| 3044F | <1% | 133 | $1K | |
| 88307 | <1% | 68 | $1K | |
| 99407 | <1% | 39 | $1K | |
| 86038 | <1% | 268 | $1K | |
| 0124A | <1% | 28 | $1K | |
| 0054A | <1% | 32 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,997 | $1K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,482 | $1K |
| 86704 | <1% | 141 | $1K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 19 | $985.34 |
| 84480 | <1% | 209 | $974.55 | |
| 90671 | <1% | 13 | $960.05 | |
| 20605 | <1% | 25 | $943.69 | |
| 73090 | <1% | 13 | $891.75 | |
| 74018 | <1% | 287 | $831.94 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 131 | $818.85 |
| 83002 | <1% | 51 | $745.88 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 717 | $738.84 |
| 93224 | <1% | 12 | $720.00 | |
| 87040 | <1% | 1,112 | $717.57 | |
| 83001 | <1% | 51 | $713.66 | |
| 3077F | <1% | 13 | $701.09 | |
| 84100 | <1% | 199 | $698.95 | |
| 1111F | <1% | 160 | $682.97 | |
| 0031A | <1% | 17 | $680.00 | |
| 72050 | <1% | 67 | $649.12 | |
| 0052A | <1% | 20 | $640.00 | |
| 96376 | <1% | 1,467 | $635.30 | |
| 82150 | <1% | 858 | $627.91 | |
| 80076 | <1% | 88 | $619.41 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 635 | $616.95 |
| 85007 | <1% | 937 | $583.63 | |
| 88141 | <1% | 67 | $547.80 | |
| 85379 | <1% | 1,225 | $503.95 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 43 | $482.79 |
| 84403 | <1% | 25 | $469.48 | |
| 82950 | <1% | 265 | $459.71 | |
| 90662 | <1% | 33 | $452.39 | |
| 86696 | <1% | 40 | $449.50 | |
| 83605 | <1% | 1,655 | $423.31 | |
| 88342 | <1% | 14 | $405.92 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,756 | $388.75 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,995 | $364.34 |
| Q3014 | Telehealth originating site facility fee | <1% | 27 | $342.34 |
| 86765 | <1% | 39 | $321.45 | |
| 82565 | <1% | 65 | $284.70 | |
| 80320 | <1% | 4,641 | $257.42 | |
| 84154 | <1% | 15 | $247.99 | |
| 83921 | <1% | 12 | $233.31 | |
| 86709 | <1% | 27 | $210.00 | |
| 73590 | <1% | 42 | $206.19 | |
| 86735 | <1% | 37 | $184.69 | |
| 87147 | <1% | 2,088 | $181.31 | |
| 80329 | <1% | 2,657 | $179.22 | |
| 84520 | <1% | 51 | $178.07 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,366 | $173.04 |
| 88300 | <1% | 36 | $148.72 | |
| 84436 | <1% | 39 | $145.92 | |
| 82248 | <1% | 34 | $135.69 | |
| 72072 | <1% | 13 | $126.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,219 | $106.73 |
| 84425 | <1% | 13 | $106.05 | |
| 87430 | <1% | 1,045 | $100.27 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 532 | $87.39 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 754 | $81.68 |
| J3490 | Unclassified drugs | <1% | 143 | $75.77 |
| 73080 | <1% | 16 | $65.89 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 18 | $64.58 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 198 | $60.89 |
| 84460 | <1% | 12 | $55.88 | |
| 86431 | <1% | 13 | $52.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,225 | $51.59 |
| 83615 | <1% | 14 | $45.27 | |
| 99460 | <1% | 277 | $39.08 | |
| 93226 | <1% | 12 | $35.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,886 | $34.61 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,387 | $32.99 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 18 | $31.30 |
| 82270 | <1% | 28 | $30.60 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 679 | $28.99 |
| 82947 | <1% | 14 | $27.51 | |
| J2704 | Injection, propofol, 10 mg | <1% | 944 | $25.27 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,966 | $22.30 |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 166 | $15.90 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,518 | $15.52 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 235 | $14.98 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 282 | $14.32 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 744 | $12.26 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 317 | $11.44 |
| 71101 | <1% | 24 | $10.61 | |
| 99462 | <1% | 96 | $10.42 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 878 | $9.98 |
| 86308 | <1% | 13 | $9.56 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 75 | $9.22 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,593 | $9.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,721 | $7.76 |
| 73140 | <1% | 14 | $4.55 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 374 | $2.74 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 396 | $2.20 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 215 | $1.84 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 238 | $1.48 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 378 | $1.48 |
| J1815 | Injection, insulin, per 5 units | <1% | 367 | $1.12 |
| 82009 | <1% | 55 | $1.02 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 943 | $0.50 |
| 96127 | 0% | 175 | $0.00 | |
| 87451 | 0% | 22 | $0.00 | |
| 86710 | 0% | 75 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 167 | $0.00 |
| 91301 | 0% | 27 | $0.00 | |
| 87280 | 0% | 14 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 52 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 14 | $0.00 |
| 87276 | 0% | 17 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 14 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 50 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 65 | $0.00 |
| 3078F | 0% | 138 | $0.00 | |
| 87279 | 0% | 12 | $0.00 | |
| 3016F | 0% | 68 | $0.00 | |
| 87260 | 0% | 12 | $0.00 | |
| 73565 | 0% | 13 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 12 | $0.00 |
| 87275 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEHTA, RAJ (CFO)